We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.205 | -8.60% | 2.18 | 2.10 | 2.26 | 2.21 | 2.18 | 2.21 | 759,115 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
TIDMIMM
RNS Number : 4207Q
Immupharma PLC
29 February 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES --------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or Immupharma plc the underlying issuer of existing shares to which voting rights are attached: ---------------------------------------------------------- --------------------------------------------- 2. Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights x ---------------------------------------------------------------------------------------------- --------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------------------------------------- --------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------------------------------------- --------- An event changing the breakdown of voting rights ---------------------------------------------------------------------------------------------- --------- Other (please specify): --------------------- ----------------------------------------------------------------------- --------- 3. Full name of person(s) Lanstead Capital LP subject to the notification obligation: -------------------------------------------- ----------------------------------------------------------- 4. Full name of shareholder(s) (if different from 3.): -------------------------------------------- ----------------------------------------------------------- 5. Date of the transaction 25 February 2016 and date on which the threshold is crossed or reached: -------------------------------------------- ----------------------------------------------------------- 6. Date on which issuer 26 February 2016 notified: -------------------------------------------- ----------------------------------------------------------- 7. Threshold(s) that is/are crossed or 3%, 4%, 5%, 6%, 7%, 8%, 9%, reached: 10%, 11%, 12%, 13%, 14%, 15% -------------------------------------------- ----------------------------------------------------------- 8. Notified details: --------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares --------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE --------------------- --------------------- ----------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights Shares Voting rights Rights --------------------- -------- ----------- ------------ ---------------------- --------------------- Direct Direct Indirect Direct Indirect --------------------- -------- ----------- ------------ ----------- --------- ---------- --------- GB0033711010 0 0 17,872,341 17,872,341 15.03% --------------------- -------- ----------- ------------ ----------- --------- ---------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights Period may be acquired if the instrument is exercised/ converted. ------------------------ ------------- --------------------------------- --------------------- ------------------- N/A ------------------------ ------------- --------------------------------- --------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights period refers to ---------------------- ------------- ------------- ------------------ --------------------- --------------------- N/A Nominal Delta ---------------------- ------------- ------------- ------------------ --------------------- ---------- --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------------------------------ -------------------------------------------- 17,872,341 15.03% ------------------------------------------------------------------------ -------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ---------------------------------------------------------------------------------------- N/A Proxy Voting: ---------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------------------- 13. Additional information: ------------------------------------------------------------- ------------------------- 14. Contact name: Lisa De Vargas, Lanstead Partners Limited ------------------------------------------------------------- ------------------------- 15. Contact telephone number: +1 (801) 895-3700 ------------------------------------------------------------- -------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLDKLBLQLFEBBK
(END) Dow Jones Newswires
February 29, 2016 03:02 ET (08:02 GMT)
1 Year Immupharma Chart |
1 Month Immupharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions